Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B4aed8eeda95a51bf8d3f1c37f86b7a6b> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B4aed8eeda95a51bf8d3f1c37f86b7a6b NCIT_P378 "NCI" @default.
- B4aed8eeda95a51bf8d3f1c37f86b7a6b type Axiom @default.
- B4aed8eeda95a51bf8d3f1c37f86b7a6b annotatedProperty IAO_0000115 @default.
- B4aed8eeda95a51bf8d3f1c37f86b7a6b annotatedSource NCIT_C68819 @default.
- B4aed8eeda95a51bf8d3f1c37f86b7a6b annotatedTarget "A recombinant immunotoxin consisting of the Fv portion of the anti-CD22 antibody covalently fused to a 38 KDa fragment of Pseudomonas exotoxin-A (PE38) with potential antineoplastic activity. The Fv portion of anti-CD22 immunotoxin CAT-8015 binds to CD22, a cell surface receptor expressed on a variety of malignant B-cells, thereby delivering the toxin moiety PE38 directly to tumor cells. Once internalized, PE38 induces caspase-mediated apoptosis via a mechanism involving mitochondrial damage and blocks translational elongation by binding to elongation factor 2 (EF-2). Anti-CD22 immunotoxin CAT-8015 exhibits a greater affinity for CD22 than its predecessor, anti-CD22 immunotoxin CAT-3888 (BL22 immunotoxin), and hence may be more effective against tumor cells expressing lower levels of CD22." @default.